Login
From:
Myasthenia Gravis News
(Uncensored)
subscribe
Immunovant positions IMVT-1402 as lead MG treatment candidate
https://myastheniagravisnews.com/news/immunovant-positions-imvt-1402-lead-mg-treatment-candidate/
links
backlinks
Tagged with:
batoclimab
immunovant
IImmunovant is prioritizing IMVT-1402 as its lead MG treatment candidate, with registrational clinical trials possible in the next year.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
